Fragasso Group Inc. Amgen Inc Transaction History

Fragasso Group Inc.

$1.24 Billion
Q3 2024

A detailed history of Fragasso Group Inc. transactions in Amgen Inc stock. As of the latest transaction made, Fragasso Group Inc. holds 26,650 shares of AMGN stock, worth $8.45 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

26,650

Previous 27,663 3.66%

Holding current value

$8.45 Million

Previous $8.64 Million 0.66%

% of portfolio

0.69%

Previous 0.74%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$309.38 - $337.38 $313,401 - $341,765	-1,013 Reduced 3.66%	26,650 $8.59 Million
Q2 2024 Jul 08, 2024	SELL	$262.75 - $319.31 $248,036 - $301,428	-944 Reduced 3.3%	27,663 $8.64 Million
Q1 2024 Apr 10, 2024	BUY	$268.87 - $324.56 $90,878 - $109,701	338 Added 1.2%	28,607 $8.13 Million
Q4 2023 Jan 08, 2024	SELL	$255.7 - $288.46 $665,331 - $750,572	-2,602 Reduced 8.43%	28,269 $8.14 Million
Q3 2023 Dec 06, 2023	SELL	$218.65 - $271.46 $179,293 - $222,597	-820 Reduced 2.59%	30,871 $8.3 Million
Q2 2023 Jul 10, 2023	SELL	$214.27 - $253.37 $1.23 Million - $1.45 Million	-5,739 Reduced 15.33%	31,691 $7.04 Million
Q1 2023 Apr 13, 2023	BUY	$225.79 - $275.2 $109,959 - $134,022	487 Added 1.32%	37,430 $9.05 Million
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $104,895 - $133,282	-458 Reduced 1.22%	36,943 $0
Q4 2022 Jan 24, 2023	SELL	$229.03 - $291.01 $8.46 Million - $10.8 Million	-36,943 Closed	0 $0
Q3 2022 Oct 13, 2022	SELL	$224.46 - $253.15 $4,489 - $5,063	-20 Reduced 0.05%	37,401 $8.43 Million
Q2 2022 Aug 30, 2022	BUY	$230.71 - $256.74 $267,854 - $298,075	1,161 Added 3.2%	37,421 $9.1 Million
Q1 2022 Apr 06, 2022	BUY	$219.27 - $242.57 $392,931 - $434,685	1,792 Added 5.2%	36,260 $8.77 Million
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $419,437 - $480,008	2,109 Added 6.52%	34,468 $7.75 Million
Q3 2021 Oct 08, 2021	BUY	$212.27 - $248.7 $587,987 - $688,899	2,770 Added 9.36%	32,359 $6.88 Million
Q2 2021 Jul 19, 2021	BUY	$233.58 - $259.14 $505,700 - $561,038	2,165 Added 7.89%	29,589 $7.21 Million
Q1 2021 May 27, 2021	BUY	$221.91 - $258.6 $396,775 - $462,376	1,788 Added 6.97%	27,424 $6.82 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $204,046 - $242,982	943 Added 3.82%	25,636 $5.89 Million
Q3 2020 Nov 05, 2020	BUY	$234.65 - $260.95 $89,870 - $99,943	383 Added 1.58%	24,693 $6.28 Million
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $8,505 - $10,437	43 Added 0.18%	24,310 $5.85 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $62,326 - $82,661	342 Added 1.43%	24,267 $4.92 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $155,909 - $200,396	824 Added 3.57%	23,925 $5.77 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $64,594 - $77,398	371 Added 1.63%	23,101 $4.47 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $186,704 - $218,859	1,120 Added 5.18%	22,730 $4.19 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $604,829 - $681,774	3,344 Added 18.31%	21,610 $4.11 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $23,370 - $27,280	131 Added 0.72%	18,266 $3.56 Million
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $350,012 - $394,593	1,889 Added 11.63%	18,135 $3.47 Million
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $49,150 - $55,206	-296 Reduced 1.79%	16,246 $3 Million
Q1 2018 May 14, 2018	SELL	$169.43 - $198.0 $16,095 - $18,810	-95 Reduced 0.57%	16,542 $2.82 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $165,245 - $184,629	979 Added 6.25%	16,637 $2.89 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $84,481 - $96,455	-505 Reduced 3.12%	15,658 $2.92 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $2.7 Million - $3.09 Million	16,163	16,163 $2.96 Million

Others Institutions Holding AMGN

# of Institutions

3,087

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.13M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fragasso Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Fragasso Group Inc. with notifications on news.

Account

Fragasso Group Inc. Amgen Inc Transaction History